Holen Sie sich die Stockscreener-App
17.03
1.55%
0.26
Handel nachbörslich:
16.93
-0.10
-0.59%
Schlusskurs vom Vortag:
$16.77
Offen:
$16.5657
24-Stunden-Volumen:
1,258
Relative Volume:
0.18
Marktkapitalisierung:
$44.57M
Einnahmen:
$5.02M
Nettoeinkommen (Verlust:
$-18.31M
KGV:
-3.7594
EPS:
-4.53
Netto-Cashflow:
$-23.40M
1W Leistung:
+0.89%
1M Leistung:
+9.55%
6M Leistung:
+26.34%
1J Leistung:
-25.83%
1-Tages-Spanne:
$16.57
$17.03
1-Wochen-Bereich:
$16.16
$17.03
52-Wochen-Spanne:
$12.12
$26.99
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Firmenname
Vtv Therapeutics Inc
Sektor
Branche
Telefon
336-841-0300
Adresse
3980 PREMIER DR, HIGH POINT, NC
Vergleichen Sie VTVT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
17.03 | 44.18M | 5.02M | -18.31M | -23.40M | -4.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-05-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-04-10 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-08 | Eingeleitet | Northland Capital | Outperform |
| 2016-09-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-09-04 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-08-24 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-08-24 | Eingeleitet | Stifel | Buy |
Alle ansehen
Vtv Therapeutics Inc Aktie (VTVT) Neueste Nachrichten
What analysts say about vTv Therapeutics Inc. stockExplosive earnings growth - jammulinksnews.com
What drives vTv Therapeutics Inc. stock priceTriple-digit return opportunities - jammulinksnews.com
What makes vTv Therapeutics Inc. stock price move sharplyBest Stocks for Capital Safety - Newser
(VTVT) Technical Data - news.stocktradersdaily.com
vTv Therapeutics Inc. Stock Analysis and ForecastSuperior profit margins - jammulinksnews.com
Is vTv Therapeutics Inc. a good long term investmentTremendous gains - jammulinksnews.com
vTv Therapeutics’ Phase 3 Diabetes Trial: A Potential Game-Changer? - TipRanks
What drives Deluxe Corporation stock priceMarket-beating performance - Jammu Links News
MAXN Stock Analysis and ForecastUnmatched market performance - Jammu Links News
Is Relay Therapeutics Inc. stock overhyped or has real potentialCapital Preservation Investment Ideas - Newser
TAOCAT(taocat by virtuals masa 1) Technical AnalysisDefensive Stock Picks with Upside - Newser
Leverage AI to analyze customer sentiment and adjust your marketing strategiesFree Deep Market Trend Analysis - Newser
Why vTv Therapeutics Inc. stock attracts strong analyst attentionFree Predictions - Newser
How vTv Therapeutics Inc. stock performs during market volatilityGroup Only Stock Signals - Newser
How MicroAlgo Inc. stock performs during market volatilityFree Access to Community with 300% Return - Newser
Why Sify Technologies Limited Equity Right stock attracts strong analyst attentionFree Real-Time Stock Data - Newser
Diabetes Clinical Trials, Companies, Therapeutic Assessment, - openPR.com
Trading (VTVT) With Integrated Risk Controls - news.stocktradersdaily.com
VTv Therapeutics Inc.(NasdaqCM: VTVT) dropped from Russell Microcap Value Index - MarketScreener
VTv Therapeutics Inc.(NasdaqCM: VTVT) dropped from Russell 3000E Value Index - MarketScreener
(VTVT) Trading Report - news.stocktradersdaily.com
vTv Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks
Transcript : VTv Therapeutics Inc.Special Call - MarketScreener
vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series - GlobeNewswire
vTv Therapeutics Showcases First-in-Class Type 1 Diabetes Treatment at HC Wainwright | VTVT Stock News - Stock Titan
(VTVT) Trading Signals - news.stocktradersdaily.com
vTv resumes Phase III oral T1D drug study - The Pharma Letter
vTv Therapeutics appoints new CFO amid Phase 3 trial By Investing.com - Investing.com South Africa
vTv Therapeutics Appoints New CFO Amidst Phase 3 Trial - TipRanks
vTv Therapeutics Appoints Michael Tung, M.D., MBA, As Chief Financial Officer - citybiz
VTv Therapeutics Names Michael Tung as Finance Chief - marketscreener.com
vTv Therapeutics (VTVT) Appoints New CFO | VTVT Stock News - GuruFocus
vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Fina - GuruFocus
VTv Therapeutics Names Michael Tung CFO, Effective Immediately - Nasdaq
vTv Therapeutics appoints new CFO amid Phase 3 trial - Investing.com
vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief - GlobeNewswire
vTv Therapeutics Advances First-in-Class Oral Type 1 Diabetes Drug as New CFO Joins - Stock Titan
VTv Therapeutics: Q1 Earnings Snapshot - Bluefield Daily Telegraph
How to Take Advantage of moves in (VTVT) - news.stocktradersdaily.com
vTv Therapeutics Highlights Cadisegliatin’s Potential for Diabetes - TipRanks
Finanzdaten der Vtv Therapeutics Inc-Aktie (VTVT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):